Acellular Pertussis Completed Phase 2 Trials for rsPSMA Vaccine (DB06361)

IndicationStatusPhase
DBCOND0031302 (Acellular Pertussis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00307567Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488Prevention